ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,778, issued on Oct. 28, was assigned to ASCENDIS PHARMA BONE DISEASES A/S (Hellerup, Denmark).
"Incremental dose finding in controlled-release PTH compounds" was invented by David Brian Karpf (Mountain View, Calif.), Kennett Sprogoe (Holte, Denmark), Lars Holten-Andersen (Vanlose, Denmark), Felix Cleemann (Mainz, Germany), Guillaume Maitro (Mannheim, Germany), Mathias Krusch (Hirschhorn, Germany), Thomas Wegge (Heidelberg, Germany) and Joachim Zettler (Heidelberg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions comprising a controlled-release PTH compound or a pharmaceutically accep...